Cargando…
A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine
Biomarkers to guide antibiotic treatment decisions have been proposed as an effective way to enhancing a more appropriate use of antibiotics. As a biomarker, procalcitonin (PCT) has been found to have good specificity to distinguish bacterial from non-bacterial inflammations. Decisions regarding ant...
Autores principales: | Azzini, Anna Maria, Dorizzi, Romolo Marco, Sette, Piersandro, Vecchi, Marta, Coledan, Ilaria, Righi, Elda, Tacconelli, Evelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290560/ https://www.ncbi.nlm.nih.gov/pubmed/32566636 http://dx.doi.org/10.21037/atm-20-1855 |
Ejemplares similares
-
Laboratory diagnosis of infectious diseases: a call for more rapid and accurate methods
por: Hu, Zhi-De, et al.
Publicado: (2020) -
Advances in laboratory assays for detecting human metapneumovirus
por: Jeong, Seri, et al.
Publicado: (2020) -
Nosocomial cross-infection of hypervirulent Listeria monocytogenes sequence type 87 in China
por: Li, Xin-Peng, et al.
Publicado: (2020) -
High clinical impact of rapid susceptibility testing on CHROMID ESBL(®) medium directly from swabs
por: Romo-Ibáñez, Álvaro, et al.
Publicado: (2020) -
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with UF-5000i urine flow cytometry to directly identify pathogens in clinical urine specimens within 1 hour
por: Sun, Chuang, et al.
Publicado: (2020)